BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8540085)

  • 1. Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
    Sparrelid E; Hägglund H; Remberger M; Ljungman P; Malmborg AS; Winiarski J; Andersson J; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3530. PubMed ID: 8540085
    [No Abstract]   [Full Text] [Related]  

  • 2. Further experience with infections in bone marrow transplant recipients.
    Winston DJ; Meyer DV; Gale RP; Young LS
    Transplant Proc; 1978 Mar; 10(1):247-54. PubMed ID: 205022
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth and development after bone marrow transplantation.
    Sanders JE; Buckner CD; Sullivan K; Doney K; Appelbaum F; Witherspoon R; Anasetti C; Storb R; Thomas ED
    Prog Clin Biol Res; 1989; 309():375-82. PubMed ID: 2675106
    [No Abstract]   [Full Text] [Related]  

  • 4. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
    Hägglund H; Ringdén O; Ljungman P; Winiarski J; Ericzon B; Tydén G
    Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic marrow for severe aplastic anaemia in Basel: current results and prospectives [proceedings].
    Speck B; Cornu P; Nissen C; Groff P; Sartorius J; Burri HP; Jeannet M
    Pathol Biol (Paris); 1978 Jan; 26(1):41-2. PubMed ID: 358082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognosis in severe bone marrow pan-aplasia; hematologic intensive care. Indications for bone marrow graft].
    Mathé G; Schwarzenberg L
    Ann Med Interne (Paris); 1977 May; 128(5):445-9. PubMed ID: 334011
    [No Abstract]   [Full Text] [Related]  

  • 7. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia.
    Azuma E; Kojima S; Kato K; Matsuyama T; Yamada Y; Kondo N; Sawada H; Hanada M; Shibata T; Tabata N; Watanabe M; Shimono Y; Deguchi T; Umemoto M; Higashikawa M; Kawasaki H; Komada Y; Sakurai M
    Bone Marrow Transplant; 1997 Jun; 19(11):1085-7. PubMed ID: 9193750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second bone marrow transplantation for severe aplastic anemia: analysis of 34 cases.
    de Medeiros CR; Bitencourt MA; Medeiros BC; Ioshizumi L; Pasquini R
    Bone Marrow Transplant; 2001 Nov; 28(10):941-4. PubMed ID: 11753548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of bone marrow transfusion in the complex therapy of hypo-plastic and aplastic anemias].
    Romanova AF; Poluboiarinova AG; Dudnik MI; Laduba TL
    Vrach Delo; 1966 Mar; 3():68-72. PubMed ID: 4865953
    [No Abstract]   [Full Text] [Related]  

  • 10. CD34-enriched peripheral stem cells infusion for graft insufficiency treatment in a pediatric patient with severe aplastic anemia after allogeneic bone marrow transplantation.
    Trakhtman P; Shipicina I; Balashov D; Scvortsova J; Dishlevaja Z; Blagonravova O; Maschan A
    Bone Marrow Transplant; 2004 Sep; 34(5):465-6. PubMed ID: 15220960
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancreatitis following allogeneic bone marrow transplantation in a patient with aplastic anemia.
    Ikushima S; Hibi S; Todo S; Morimoto A; Sawada T; Tsunamoto K; Imashuku S
    Bone Marrow Transplant; 1996 Aug; 18(2):485-6. PubMed ID: 8864474
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-pathological conference LVII. Complications of bone marrow grafting in aplastic anemia].
    Saarinen U; Rapola J
    Duodecim; 1979; 95(17):1092-103. PubMed ID: 391535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transfusion of allogeneic bone marrow in hypo- and aplastic anemia].
    Bogoiavlenskaia MP; Frinovskaia IV; Orlov GP; Kochemasov VV; Liubimova LS
    Probl Gematol Pereliv Krovi; 1975 Dec; 20(12):23-8. PubMed ID: 781662
    [No Abstract]   [Full Text] [Related]  

  • 14. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
    Dulley FL; Vigorito AC; Aranha FJ; Sturaro D; Ruiz MA; Saboya R; Macedo MC; Da Silva RL; Chamone DA; Mehta J; Bacigalupo A; De Souza CA
    Bone Marrow Transplant; 2004 Jan; 33(1):9-13. PubMed ID: 14578930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aplastic anemia treated by isogeneic or allogeneic bone marrow transplantation (author's transl)].
    Harada M; Kitao T; Sugiyama T; Kodo H; Otake S; Okafuji K; Yoshida T; Funada H; Tsukuda K; Ishino C; Mori T; Fujita S; Ishizaki T; Niwa K; Mitamura E; Matsue K; Hisada T; Nakamura S; Hattori K
    Rinsho Ketsueki; 1978 Nov; 19(11):1509-18. PubMed ID: 368376
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
    Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
    Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crux of the log rank test. Re: Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Fuhrer M. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Haematologica 2007; 92:11-8.
    Linden T; Gerss J; Jürgens H
    Haematologica; 2007 Dec; 92(12):e122. PubMed ID: 18055974
    [No Abstract]   [Full Text] [Related]  

  • 18. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term renal function following bone marrow transplantation.
    Grönroos MH; Bolme P; Winiarski J; Berg UB
    Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.